Skip to main content
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
Loading...
Newsroom
Investors
Careers
< Back
Careers
Careers
Working at Ipsen
Our Culture
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
X
Loading...
Singapore
<
Global
EN
FR
Annual Report
EN
FR
Americas
Asia Pacific
Europe
Middle East & Africa
Brazil
Canada
United States
Mexico
Colombia
Australia
China
Singapore
South Korea
Japan
Belgium
Ukraine
UK
Germany
France
Nordics
Greece
Italy
Netherlands
Spain
Poland
Russia
Czech Republic
Romania
Hungary
Slovakia
Switzerland
Austria
UAE & Gulf
Saudi Arabia
Home
Company
< Back
Company
Company
History
Expertise
< Back
Expertise
Oncology
Rare Disease
Neuroscience
Science
< Back
Science
Pipeline
Clinical Trials
< Back
Clinical Trials
Find Clinical Trials
Products
< Back
Products
Bvlvay® (odevixibat)
Cabometyx® (cabozantinib)
Diphereline® (triptorelin pamoate or acetate)
Dysport® (abobotulinumtoxinA)
Iqirvo® (elafibranor)
Somatuline® Autogel® (lanreotide acetate)
Scientific Events
< Back
Scientific Events
Events in Singapore
Close menu
Post navigation
Previous
Bylvay Package Insert
Bylvay Package Insert
-
16 September 2026
-
0 mins read
Post navigation
Previous
Related Documents
Bylvay Package Insert
(726 KB)
X
You are now leaving Ipsen Singapore website. To continue, please click on
Continue
?
